Overbought Stocks — Financial View · Pharmaceutical Preparations
31 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Financial columns. Filtered to Pharmaceutical Preparations. Updated
Filters2
1–31 of 31
| ARTL | ARTELO BIOSCIENCES, INC. | $30M | — | — | — | — | 3.00 | 0.29 | — | — | — | 6.59 | +0.15% | 811 |
| VOGX | Vogenx, Inc. | — | — | — | — | — | — | — | — | — | — | 32.42 | +0.00% | 4K |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.0B | — | -37.9% | -42.1% | -42.1% | 15.57 | 0.11 | — | — | — | 84.96 | +0.13% | 161K |
| LGVN | Longeveron Inc. | $186M | — | — | — | — | 2.63 | 0.01 | 69.8% | — | — | 6.61 | -3.22% | 973 |
| XBIO | Xenetic Biosciences, Inc. | $11M | — | -35.5% | -40.8% | — | 7.43 | 0.04 | 0.0% | -81.0% | -75.9% | 4.64 | +7.66% | 1K |
| CMMB | Chemomab Therapeutics Ltd. | — | — | -65.1% | -72.9% | — | 9.08 | 0.12 | — | — | — | 2.82 | +3.30% | 3K |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $238M | — | -0.6% | -0.6% | -0.6% | 79.19 | 0.03 | — | — | -58.5% | 2.21 | +31.55% | 542K |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.0B | — | 4.5% | 10.2% | 5.7% | 2.40 | 0.81 | 47.7% | 15.7% | 10.8% | 23.85 | +0.44% | 24K |
| RNXT | RenovoRx, Inc. | $106M | — | — | — | — | 5.74 | 0.28 | 84.4% | — | — | 2.34 | -9.30% | 77K |
| BMEA | Biomea Fusion, Inc. | $138M | — | -88.2% | — | — | 3.47 | 2.04 | — | — | — | 1.91 | -1.04% | 35K |
| HOWL | Werewolf Therapeutics, Inc. | $46M | — | — | — | — | 2.91 | 1.97 | — | — | — | 0.94 | -4.65% | 12K |
| HCM | HUTCHMED (China) Ltd | — | — | -6.0% | -8.6% | -8.0% | 4.96 | 0.08 | — | -26.7% | -19.3% | 14.09 | +17.22% | 13K |
| QNRX | Quoin Pharmaceuticals, Ltd. | — | — | — | — | — | 1.76 | 2.04 | — | — | — | 7.40 | +13.32% | 8K |
| VBIO | Valion Bio, Inc. | $62M | — | -57.7% | — | — | 1.11 | 4.85 | 0.3% | — | — | 2.80 | -10.26% | 174 |
| JANX | Janux Therapeutics, Inc. | $1.2B | — | -10.2% | -11.1% | -11.1% | 16.35 | 0.09 | — | — | — | 19.83 | +0.71% | 72K |
| CELU | Celularity Inc | $54M | — | -85.5% | — | — | 0.15 | -0.45 | 24.4% | — | — | 1.85 | +0.82% | 3K |
| FTH | Faeth Therapeutics, Inc. | — | — | — | — | — | 19.69 | 0.00 | — | — | — | 40.27 | +2.82% | 21K |
| OGN | Organon & Co. | $3.6B | 0.6% | 1.6% | 20.8% | 2.2% | 1.95 | 8.50 | 52.7% | — | 3.4% | 13.78 | +0.00% | 148K |
| GLMD | Galmed Pharmaceuticals Ltd. | — | — | -55.3% | -65.3% | — | 6.55 | 0.00 | — | — | — | 4.01 | -1.72% | 229 |
| SRPT | Sarepta Therapeutics, Inc. | $2.4B | — | -4.3% | -8.9% | -5.8% | 4.42 | 0.55 | — | -10.2% | -9.8% | 22.99 | -0.95% | 180K |
| CYCN | Cyclerion Therapeutics, Inc. | $24M | — | -96.8% | — | — | 0.82 | — | — | — | — | 5.14 | +13.47% | 5K |
| OMER | Omeros Corp | $1.4B | — | 43.5% | — | — | 1.95 | -1.43 | — | -98.7% | — | 19.12 | +1.27% | 49K |
| ARCT | Arcturus Therapeutics Holdings Inc. | $442M | — | -41.6% | -54.3% | -49.9% | 5.88 | 0.09 | — | — | — | 15.56 | -7.07% | 41K |
| LEXX | Lexaria Bioscience Corp. | $305M | — | — | — | — | 10.60 | 0.09 | 27.5% | — | — | 12.31 | -7.44% | 764 |
| APLM | Apollomics Inc. | — | — | — | — | — | — | — | — | — | — | 26.73 | +0.53% | 2 |
| NGEN | NERVGEN PHARMA CORP. | — | — | — | — | — | — | — | — | — | — | 2.31 | -0.86% | 27K |
| VSTM | Verastem, Inc. | $723M | — | -98.2% | — | — | 2.25 | 0.81 | — | — | — | 7.98 | -0.25% | 151K |
| AQST | Aquestive Therapeutics, Inc. | $671M | — | -59.2% | — | — | 7.19 | -0.97 | 67.0% | -97.5% | — | 5.35 | -0.47% | 97K |
| MNOV | MEDICINOVA INC | $79M | — | -26.6% | -28.9% | — | 8.75 | 0.00 | — | — | — | 1.61 | +11.76% | 3K |
| KYNB | KYNTRA BIO, INC. | $34M | — | — | — | — | 2.69 | -2.49 | 6.3% | — | — | 8.50 | -0.53% | 243 |
| EOLS | Evolus, Inc. | $598M | — | -13.8% | — | -27.3% | 1.70 | -5.07 | 66.7% | -5.9% | -10.8% | 9.06 | +0.06% | 42K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.